Edwards Lifesciences EV/EBIT EW

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026: 23.5×
10-year median: 31.0×
Against its 10-year history: 4th; percentile: 0 is its lowest day, 100 its highest
10-year range: 20.8× to 59.1×
Peer median: 21.5×

Edwards Lifesciences' EV/EBIT is 23.5× as of Oct 23, 2026.

That is below its ten-year median of 31.0×, lower than on 96% of days in the last ten years.

Over that time it ranged from 20.8× in Oct 2023 to 59.1× in Nov 2019.

The median for 7 medical device stocks of a similar size is 21.5×.

EV/EBIT over time

median 31×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	23.5×	22.2×	28.3×
2025	28.9×	24.4×	28.9×
2024	27.5×	23.7×	37.4×
2023	26.9×	20.8×	31.2×
2022	26.0×	23.8×	45.1×
2021	47.7×	38.4×	53.3×
2020	45.7×	28.9×	57.3×
2019	56.4×	35.1×	59.1×
2018	35.5×	24.9×	42.7×
2017	24.2×	22.0×	29.4×
2016	25.6×	22.7×	35.6×
2015	31.5×	11.1×	35.3×
2014	11.5×	8.3×	23.3×
2013	12.8×	11.9×	30.5×
2012	28.8×	26.3×	40.8×
2011	27.9×	24.6×	35.5×

Against its peers

Companies in Medical - Devices nearest Edwards Lifesciences' size, closest first, today.

Company	EV/EBIT
EWEdwards Lifesciences	23.5×
BSXBoston Scientific	18.2×
GEHCGE HealthCare Technologies	14.7×
DXCMDexCom	25.3×
SYKStryker	23.4×
MDTMedtronic	20.7×
ZBHZimmer Biomet	21.5×
ABTAbbott Laboratories	28.2×
Peer median	21.5×

Where Edwards Lifesciences ranks

#9of 13Medical device stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Edwards Lifesciences

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.